NCC to construct Novozymes Innovation Campus
NCC has been commissioned by the biotech company Novozymes to construct a modern campus – a center for biotechnology research and business development – north of Copenhagen, Denmark. The order is worth SEK approximately 865 million.“At NCC, we are very pleased to play a part in realizing Novozymes’ vision through the construction of a new and exciting innovation campus. The physical environment is crucial to provide people with opportunities to develop creatively,” says Palle Bjerre Rasmussen, Head of NCC Building in Denmark.NCC will construct the first phase of Novozymes Innovation
Read original